Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Cancer & Clinical Oncology|April 1, 1989
High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancerP O Mulder, P H Willemse, J G Aalders, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancerN H Mulder, P O Mulder, D T Sleijfer, et al.
Cancer|November 15, 1989
Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral versus partial parenteral plus enteral nutritionP O Mulder, J G Bouman, J A Gietema, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumorsP O Mulder, E G de Vries, H S Koops, et al.
The Netherlands Journal of Medicine|April 1, 1989
Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumoursP O Mulder, P Schröder, H G de Vries-Hospers, et al.
Critical Care Medicine|February 1, 1992
Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humansA S Dofferhoff, V J Bom, H G de Vries-Hospers, et al.
Haemostasis|January 1, 1989
Bleeding prophylaxis in autologous bone marrow transplantation for solid tumors. Comparison of cryopreserved autologous and fresh allogeneic single-donor plateletsP O Mulder, A Maas, E G de Vries, et al.
International Journal of Cancer|June 19, 1991
In vitro and in vivo modulation of multi-drug resistance with amiodaroneW T van der Graaf, E G de Vries, D R Uges, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1985
High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II studyP E Postmus, N H Mulder, H G de Vries-Hospers, et al.
Anticancer Research|July 1, 1995
Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancerN H Mulder, W V Dolsma, P O Mulder, et al.
Pageof 3